
OpenAI and Anthropic have launched significant updates to their flagship AI models, GPT-5.3-Codex and Opus 4.6, enhancing capabilities in coding and enterprise automation. These releases mark a pivotal moment in the AI industry, showcasing advancements in self-improving AI and multi-agent collaboration.


OpenAI and Ginkgo Bioworks have integrated GPT-5 into an automated lab to enhance cell-free protein synthesis, achieving significant cost reductions and yield improvements in protein production.




Insilico Medicine and GenEditBio executives discuss how AI is addressing the labor shortage in rare disease treatment at Web Summit Qatar, highlighting advancements in drug discovery and gene editing.

OpenAI's decision to retire the GPT-4o model has ignited protests from users who feel a deep emotional connection to the AI. The backlash highlights the dangers of AI companions, as lawsuits allege that the model's responses contributed to mental health crises.







Researchers from Asari AI, MIT CSAIL, and Caltech introduce a new framework called ENCOMPASS that separates logic from inference in AI agents, improving scalability and reliability in enterprise applications.